These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3080760)

  • 1. Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat.
    Vaccarino FJ; Amalric M; Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1986 Jan; 24(1):61-5. PubMed ID: 3080760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine.
    Lynch MR; Carey RJ
    Pharmacol Biochem Behav; 1989 Feb; 32(2):577-80. PubMed ID: 2498910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
    Swerdlow NR; Amalric M; Koob GF
    Pharmacol Biochem Behav; 1987 Apr; 26(4):765-9. PubMed ID: 3110795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat.
    Swerdlow NR; Vaccarino FJ; Koob GF
    Pharmacol Biochem Behav; 1985 Sep; 23(3):499-501. PubMed ID: 4048244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral mesolimbicocortical dopamine denervation decreases locomotion in the open field and after amphetamine.
    Jeste DV; Smith GP
    Pharmacol Biochem Behav; 1980 Mar; 12(3):453-7. PubMed ID: 7393946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the mechanism of the long-lasting antagonistic effect of caerulein on amphetamine-induced hyperactivity in rats.
    Matsubara K; Matsushita A
    Gen Pharmacol; 1986; 17(1):13-7. PubMed ID: 2936646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.
    Spyraki C; Fibiger HC; Phillips AG
    Psychopharmacology (Berl); 1983; 79(2-3):278-83. PubMed ID: 6405439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system.
    Joyce EM; Koob GF
    Psychopharmacology (Berl); 1981; 73(4):311-3. PubMed ID: 6789349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate neural substrates of the locomotor-activating properties of amphetamine, heroin, caffeine and corticotropin releasing factor (CRF) in the rat.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1985 Aug; 23(2):303-7. PubMed ID: 3877311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
    Arnt J
    Life Sci; 1985 Aug; 37(8):717-23. PubMed ID: 3927097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of d-amphetamine, alpha-flupenthixol, and mesolimbic dopamine depletion on a test of attentional switching in the rat.
    Robbins TW; Evenden JL; Ksir C; Reading P; Wood S; Carli M
    Psychopharmacology (Berl); 1986; 90(1):72-8. PubMed ID: 3094065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation.
    Vaccarino FJ; Corrigall WA
    Brain Res Bull; 1987 Nov; 19(5):545-9. PubMed ID: 3690365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of D1 dopamine receptors in the medial prefrontal cortex attenuates amphetamine- and methamphetamine-induced locomotor activity in the rat.
    Hall DA; Powers JP; Gulley JM
    Brain Res; 2009 Dec; 1300():51-7. PubMed ID: 19733155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.